The length of time a patient with advanced gastric cancer can survive is an uncertainty that varies from person to person. The survival period of patients who have undergone systematic and regular treatment in hospital is relatively longer than those who do not undergo treatment. In clinical practice, gastric cancer is a disease that is very prone to recurrence and metastasis and requires close attention and focus. Once lymph node metastasis or bloodstream metastasis occurs, it is usually understood to be advanced gastric cancer.
The five-year survival rate for patients with advanced gastric cancer is generally around 10 percent, but the survival time for patients with advanced gastric cancer depends on their specific condition and is also influenced by whether they have received proper treatment and their own physical functions. The focus of attention is on using all means to prolong the survival time of patients with advanced gastric cancer and improve their quality of life.